Literature DB >> 23873765

Genus-optimized strategy for the identification of chlamydial type III secretion substrates.

Kelley M Hovis1, Sergio Mojica, Jason E McDermott, Laura Pedersen, Chana Simhi, Roger G Rank, Garry S A Myers, Jacques Ravel, Ru-ching Hsia, Patrik M Bavoil.   

Abstract

Among chlamydial virulence factors are the type III secretion (T3S) system and its effectors. T3S effectors target host proteins to benefit the infecting chlamydiae. The assortment of effectors, each with a unique function, varies between species. This variation likely contributes to differences in host specificity and disease severity. A dozen effectors of Chlamydia trachomatis have been identified; however, estimates suggest that more exist. A T3S prediction algorithm, SVM-based Identification and Evaluation of Virulence Effectors (SIEVE), along with a Yersinia surrogate secretion system helped to identify a new T3S substrate, CT082, which rather than functioning as an effector associates with the chlamydial envelope after secretion. SIEVE was modified to improve/expand effector predictions to include all sequenced genomes. Additional adjustments were made to the existing surrogate system whereby the N terminus of putative effectors was fused to a known effector lacking its own N terminus and was tested for secretion. Expansion of effector predictions by cSIEVE and modification of the surrogate system have also assisted in identifying a new T3S substrate from C. psittaci. The expanded predictions along with modifications to improve the surrogate secretion system have enhanced our ability to identify novel species-specific effectors, which upon characterization should provide insight into the unique pathogenic properties of each species.
© 2013 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  Chlamydia; effector; type III secretion

Mesh:

Substances:

Year:  2013        PMID: 23873765      PMCID: PMC3838470          DOI: 10.1111/2049-632X.12070

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  28 in total

1.  Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae.

Authors:  R Lugert; M Kuhns; T Polch; U Gross
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 3.402

2.  Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates.

Authors:  Kenneth A Fields; Elizabeth R Fischer; David J Mead; Ted Hackstadt
Journal:  J Bacteriol       Date:  2005-09       Impact factor: 3.490

Review 3.  Bioinformatics, genomics and evolution of non-flagellar type-III secretion systems: a Darwinian perspective.

Authors:  Mark J Pallen; Scott A Beatson; Christopher M Bailey
Journal:  FEMS Microbiol Rev       Date:  2005-04       Impact factor: 16.408

4.  A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates.

Authors:  Agathe Subtil; Cédric Delevoye; María-Eugenia Balañá; Laurence Tastevin; Stéphanie Perrinet; Alice Dautry-Varsat
Journal:  Mol Microbiol       Date:  2005-06       Impact factor: 3.501

5.  Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis.

Authors:  J T Grayston; M B Aldous; A Easton; S P Wang; C C Kuo; L A Campbell; J Altman
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

6.  Host-Cell Survival and Death During Chlamydia Infection.

Authors:  Songmin Ying; Matthew Pettengill; David M Ojcius; Georg Häcker
Journal:  Curr Immunol Rev       Date:  2007

7.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

8.  Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.

Authors:  S Hower; K Wolf; K A Fields
Journal:  Mol Microbiol       Date:  2009-05-15       Impact factor: 3.501

9.  Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis.

Authors:  Sara V Pais; Catarina Milho; Filipe Almeida; Luís Jaime Mota
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

10.  Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus.

Authors:  Anne-Sofie Hobolt-Pedersen; Gunna Christiansen; Evy Timmerman; Kris Gevaert; Svend Birkelund
Journal:  FEMS Immunol Med Microbiol       Date:  2009-07-02
View more
  14 in total

Review 1.  New frontiers in type III secretion biology: the Chlamydia perspective.

Authors:  K E Mueller; G V Plano; K A Fields
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

2.  A Same-Genus Screening Approach Reveals Novel Effectors and New Possibilities for Investigating Chlamydia Pathogenesis.

Authors:  John D Ryan; David E Nelson
Journal:  J Bacteriol       Date:  2021-03-22       Impact factor: 3.490

3.  Expression and targeting of secreted proteins from Chlamydia trachomatis.

Authors:  Laura D Bauler; Ted Hackstadt
Journal:  J Bacteriol       Date:  2014-01-17       Impact factor: 3.490

4.  Analysis of CPAF mutants: new functions, new questions (the ins and outs of a chlamydial protease).

Authors:  Patrik M Bavoil; Gerald I Byrne
Journal:  Pathog Dis       Date:  2014-08       Impact factor: 3.166

5.  Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors.

Authors:  Vítor Borges; Miguel Pinheiro; Minia Antelo; Daniel A Sampaio; Luís Vieira; Rita Ferreira; Alexandra Nunes; Filipe Almeida; Luís J Mota; Maria J Borrego; João P Gomes
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  SINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighbors.

Authors:  Sergio A Mojica; Kelley M Hovis; Matthew B Frieman; Bao Tran; Ru-ching Hsia; Jacques Ravel; Clifton Jenkins-Houk; Katherine L Wilson; Patrik M Bavoil
Journal:  Mol Biol Cell       Date:  2015-03-18       Impact factor: 4.138

7.  Analysis of Polymorphic Membrane Protein Expression in Cultured Cells Identifies PmpA and PmpH of Chlamydia psittaci as Candidate Factors in Pathogenesis and Immunity to Infection.

Authors:  Sarah Van Lent; Winnok H De Vos; Heather Huot Creasy; Patricia X Marques; Jacques Ravel; Daisy Vanrompay; Patrik Bavoil; Ru-Ching Hsia
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

8.  The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion.

Authors:  Maria da Cunha; Sara V Pais; Joana N Bugalhão; Luís Jaime Mota
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

9.  Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis.

Authors:  Konrad E Mueller; Kenneth A Fields
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

10.  Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system.

Authors:  Maria da Cunha; Catarina Milho; Filipe Almeida; Sara V Pais; Vítor Borges; Rui Maurício; Maria José Borrego; João Paulo Gomes; Luís Jaime Mota
Journal:  BMC Microbiol       Date:  2014-02-17       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.